Despite the granting of a Therap eutic Use Exemption, the presence of salbutamol in urine in excess of 1000 ng/mL will be considered as an Adverse Analytical Finding  unless the Athlete proves, through a controlled pharmacokinetic study, that th e abnormal result was the consequence of the use of a therap eutic dose of inhaled salbutamol.